Tymora Analytical is an innovative R&D laboratory specializing in non-invasive biomarker discovery to better understand and diagnose diseases such as cancer and Alzheimer's.
Currently, genetic screens dominate the market. However, genes just show one's predisposition to developing a disease- for example, a 40% chance of getting breast cancer. In addition, CTCs and cfDNA are present at very low levels and are extremely difficult to detect at early stages.
We've developed new EV analysis services for biomarker identification-EVtrap-to help other researchers detect thousands of active disease proteins and phosphoproteins from biofluids like blood, urine, and saliva. And, we would love to collaborate with you for more biomarker discoveries.
Partial Data by Infogroup (c) 2025. All rights reserved.
